Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
about
On-X versus St Jude Medical Regent mechanical aortic valve prostheses: early haemodynamics.Pregnancy complicated by valvular heart disease: an update.Current Clinical Evidence on Rapid Deployment Aortic Valve Replacement: Sutureless Aortic Bioprostheses.Anticoagulation dilemma in a high-risk patient with On-X valves.Anticoagulant independent mechanical heart valves: viable now or still a distant holy grailAortic valve replacement in young and middle-aged adults: looking beyond the tree that hides the forest.The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.Emerging trends in heart valve engineering: Part II. Novel and standard technologies for aortic valve replacement.Mechanical versus biological aortic valve replacement strategies.Advances in the management of severe aortic stenosis.Bileaflet mechanical valve replacement: an assessment of outcomes with 30 years of follow-up.Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.Mechanical versus bioprosthetic aortic valve replacement.Optimal Intensity of Warfarin Therapy in Patients With Mechanical Aortic Valves.10-year results of On-X bileaflet mechanical heart valve in the aortic position: low target INR regimen in Japanese.Low target-INR anticoagulation is safe in selected aortic valve patients with the Medtronic Open Pivot mechanical prosthesis: long-term results of a propensity-matched comparison with standard anticoagulation.2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations.[Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment].Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation.Aortic valve replacement in younger patients.2017 ESC/EACTS Guidelines for the management of valvular heart disease.Reduction of aberrant aortic haemodynamics following aortic root replacement with a mechanical valved conduit.A reoperation of thrombosed On-X valve detected by multidetector-row computed tomography.Obstructed prosthetic valve thrombosis of a pure carbon bi-leaflet aortic valve.Low-dose anticoagulation after isolated mechanical aortic valve replacement with Liva Nova Bicarbon prosthesis: A post hoc analysis of LOWERING-IT Trial.Transcatheter Aortic Valve Replacement in Intermediate- and Low-Risk Patients.
P2860
Q33801864-BA43ADF5-4C3F-479B-8D4A-AEBF2171FF20Q35021794-20501E80-905E-4FC3-9D74-DBF74D934AE4Q36685635-F936D0DE-817A-416B-B22E-2DDC80F3ABFDQ36939463-8095FAC2-B762-462D-81F8-1DB6E84AEEF2Q37583742-43E82083-6849-467F-BDFD-8B1EBF7AA914Q37680763-F879AC8D-7EF5-4AF5-B920-C8F9C9BB01FDQ38247892-CD4F93BD-0BB6-4EA3-979B-78AFC982B002Q38275495-A7D5F663-D10D-456E-B1ED-BF3CDDF73B68Q38672242-CDC4CB20-5EDE-4AAE-9084-EC302CD03FC6Q38737121-91DD91B5-D523-4918-BF8B-AC4B6ACD1193Q38848781-4E83B553-B21D-44C2-A28E-AE00321386F4Q39190576-84653948-32D3-4E30-9D08-952DCA9C9D42Q39263473-38E8429C-6398-41A2-89C0-71F9998E246DQ47856582-C2B129D2-E9E2-4FA8-AF75-BCDB5F6361A7Q48049318-073C1C71-6624-4B25-96C2-A6CB943B1992Q48679193-0B073A7D-E0AA-407C-B734-03159A1726E5Q49516122-D9154C4E-989B-4F8F-A37C-40A0B232F4ACQ49935648-3C326110-0178-41EF-A61F-DE6D90529800Q50089781-522AB414-5DF8-48A2-BA6E-9E6EFFBD26B4Q50094107-A61B6B48-C55D-4131-A860-A5915DEA9AF0Q50196541-19807C89-E364-4C16-8E35-70B0020133A0Q50635575-14D1AA83-80C3-4D1D-8631-D38743D14D21Q51013214-826F7DF1-5532-4275-AC5A-69248DCFB121Q51316076-8F415990-1032-4861-BC72-5D75100C487AQ55036390-6C2F5E2B-5EC5-4794-8BF9-957F8CB151DDQ55492330-8322EFF8-6CAD-4DD0-B8B9-2A6928BB6A3C
P2860
Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Reduced anticoagulation after ...... tional device exemption trial.
@en
Reduced anticoagulation after ...... tional device exemption trial.
@nl
type
label
Reduced anticoagulation after ...... tional device exemption trial.
@en
Reduced anticoagulation after ...... tional device exemption trial.
@nl
prefLabel
Reduced anticoagulation after ...... tional device exemption trial.
@en
Reduced anticoagulation after ...... tional device exemption trial.
@nl
P2093
P1476
Reduced anticoagulation after ...... tional device exemption trial.
@en
P2093
Allen Graeve
Birger Rhenman
Bobby Kong
Chad Hughes
Charles Anderson
Dennis Nichols
Gulshan Sethi
John Puskas
Lilibeth Fermin
Marc Gerdisch
P304
1202-1210; discussion 1210-1
P356
10.1016/J.JTCVS.2014.01.004
P407
P577
2014-01-12T00:00:00Z